The Fenland Study (Phase 1) began in 2005, with further phases and sub-studies successfully launched and completed in the following years. The study’s overall success is a result of the wide range of people who have worked on it over the years.
Phases 1, 2, and 3 investigators
Chief Investigator
Principal Investigators
Dr Søren Brage
Professor Nita Forouhi
Professor Simon Griffin
Dr Kirsten Rennie
COVID-19 study (2020-2021) investigators
MRC Epidemiology Unit
Nick Wareham
Kirsten Rennie
Effrossyni Gkrania-Klotsas
Albert Koulman
Soren Brage
Carina Tyrrell
Vickie Braithwaite
Nita Forouhi
Simon Griffin
Claudia Langenberg
Department of Psychiatry
Public Health England
Aliko Ahmed
David Wyllie
Funders
The Fenland Study is core funded by the Medical Research Council. Metabolomics and extension of the GWAS analysis to cover the entire cohort was funded by the MRC Omics call (MC_PC_13046).
